So--for the science-inclined posters out there (Oh
Post# of 148236
Quote:
So--for the science-inclined posters out there (Ohm?)-- since leronlimab seems to work on cancer, should Cytodyn include cancer as an indication in the new protocol? Even as a secondary outcome?
That would extend the length of the trial quite a bit. So fast and cheap would go out the window.